Recent Comments

Interesting points Joel. Regarding non-dihdropyridine CCBs, this is a still a relatively unanswered question whether they offer specific advantages over DHP-CCBs. At one time, I heard Bayer (promoting Adalat XL at the time) was considering a head-to-head trial with diltiazem XC. But of course, it never happened and so the theory never progressed beyond George Bakris' original work (a good article to add this repository). The apparent advantage of DHPs over non-DHPs for blood pressure potency also didn't help the cause of non-DHPs. Jordan
  1.   about 5 years ago
A pivotal trial that changed it all for me
  1.   about 5 years ago
Still nothing yet Joel. I would expect that we will see something soon in a high-impact journal. Jordan
  1.   about 6 years ago
Thanks for sharing Tushar and TOUNJ!
  1.   about 6 years ago
My pleasure. I hope you like it. We are always adding new material to the site. For older material, it's probably best to use flash on a desktop computer. Newer resources work on all platforms. Jordan
  1.   about 6 years ago
The person has not posted any comments on the site yet
Impossible de charger le contenu de l'info-bulle.
ukidneyisup